Featured Post

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...

Thursday, March 30, 2017

Results #39;positive#39; for nasal spray 3rd phase trials: Glenmark

http://ift.tt/2niMpIe
Results #39;positive#39; for nasal spray 3rd phase trials: Glenmark The results for GSP 301, a fixed-dose combination of mometasone furoate 25 mcg and olopatadine hydrochloride 665 mcg are from a recently completed phase III trial assessing its efficacy and safety versus mometasone, olopatadine or placebo, it said in a BSE filing.

March 30, 2017 at 01:59PM

http://ift.tt/2okkl4w

from

http://ift.tt/2okkl4w
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)